DJIA 16,943.81 28.74 0.17%
NASDAQ 4,415.49 19.29 0.44%
S&P 500 1,967.57 2.89 0.15%
market minute promo

163.21 0.32 (0.20%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ALXN $163.21 0.20%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $162.75
Previous Close $162.89
Daily Range $160.89 - $163.75
52-Week Range $100.50 - $185.43
Market Cap $32.3B
P/E Ratio 98.72
Dividend (Yield) $0.00 (0.0%)
Volume 724,261
Average Daily Volume 1,206,894
Current FY EPS $4.55

Sector

Healthcare

Industry

Drugs

Alexion Pharmaceuticals, Inc. (ALXN) Description

A biotechnology company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions. Website: http://www.alexionpharm.com/

News & Commentary

Can Alexion Pharmaceuticals Remain a Top Orphan Drugmaker in the Years Ahead?

Can Alexion Pharmaceuticals retain its top orphan drug maker status, or will this one trick pony lose its audience?

S&P 500 Movers: GRMN, AA

UBS Very Bullish on Biotech Stocks Ahead of Second-Quarter Earnings

Raptor Pharmaceuticals CEO to Retire, Appoints Successor - Analyst Blog

Alexion Pharma Looks To Life Beyond Its Blockbuster

Raptor Announces CEO Succession Plan; Dr. Christopher Starr To Retire As CEO At Year-End 2014, Julie

Raptor Announces CEO Succession Plan; Dr. Christopher Starr To Retire As CEO At Year-End 2014, Julie Anne Smith Named President And CEO-Designate

Citi Sees Plenty Of Q2 Earnings Beats Ahead In Biotech Sector

4 Biotech Stocks Worth A Look Ahead Of FDA Approvals

The Path to FDA Approval Could Launch Seven Biotech Stocks Much Higher

Friday's ETF with Unusual Volume: MTUM

VRTX, ICPT And ALXN, 3 Drugs Stocks Pushing The Industry Lower

See More ALXN News...

ALXN's Top Competitors

ALXN $163.21 (0.20%)
Current stock: ALXN
AMGN $119.77 (0.69%)
Current stock: AMGN
GILD $88.73 (-0.24%)
Current stock: GILD
BIIB $322.22 (0.97%)
Current stock: BIIB